BTAI
BioXcel Therapeutics, Inc.
$0.80
-0.24 (-22.87%)
At close · Jul 8
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$24.77M
Shares
30,877,605
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$642K
-71.7%
FY2025
Net Income
-$69.9M
-17.3%
FY2025
Gross Margin
74.45%
+69pp
FY2025
Operating Margin
-7859.97%
-4892.4pp
FY2025
Diluted EPS
-$5.73
+75.6%
FY2025
Operating Cash Flow
-$57.62M
+20%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| $680K | $642K | $2.27M | $1.38M | $375K | — | — | — | — | — | |
| $433K | $164K | $2.14M | $1.26M | $20K | — | — | — | — | — | |
| $247K | $478K | $123K | $120K | $355K | — | — | — | — | — | |
| — | 74.45% | 5.43% | 8.7% | 94.67% | — | — | — | — | — | |
| $28.65M | $30.25M | $30.44M | $84.33M | $91.24M | $52.71M | $58M | $25.8M | $14.56M | $2.69M | |
| $55.51M | — | — | — | — | $54.23M | $24.3M | $7.8M | $5.4M | $1.85M | |
| $21.99M | $20.49M | $34.49M | $83.41M | $68.76M | $54.23M | — | — | — | — | |
| $309K | — | — | — | — | $297K | $188K | $156K | $17K | $1000 | |
| $0 | $194K | $2.44M | $4.16M | — | — | — | — | — | — | |
| $120.71M | — | — | — | — | $106.94M | $82.3M | $33.6M | $19.96M | $4.54M | |
| $51.27M | $51.1M | $69.51M | $173.16M | $160.02M | $106.94M | — | — | — | — | |
| -$50.59M | -$50.46M | -$67.25M | -$171.78M | -$159.65M | -$106.94M | -$82.3M | -$33.6M | -$19.96M | -$4.54M | |
| — | -7859.97% | -2967.56% | -12447.97% | -42572% | — | — | — | — | — | |
| -$111.73M | — | — | — | — | -$106.64M | -$82.11M | -$33.45M | -$19.95M | -$4.54M | |
| $17.19M | $16.98M | $15.13M | $13.31M | $8.21M | $40K | $27K | $20K | — | — | |
| $998K | $1.07M | $2.6M | $5.65M | $2.53M | $44K | $155K | — | — | — | |
| -$8.56M | -$3.52M | $20.17M | $394K | -$427K | — | — | — | — | — | |
| — | $0 | $0 | $0 | — | — | — | — | — | — | |
| -$75.33M | -$69.9M | -$59.6M | -$179.05M | -$165.76M | -$106.93M | -$82.17M | -$32.97M | -$19.27M | -$4.54M | |
| — | -10887.38% | -2630.14% | -12974.86% | -44201.87% | — | — | — | — | — | |
| USD/shares | — | -$5.73 | -$23.51 | -$98.33 | -$94.72 | -$64.80 | -$60.64 | — | — | — |
| USD/shares | — | -$5.73 | -$23.51 | -$98.33 | -$94.72 | -$64.80 | -$60.64 | — | — | — |
| shares | — | 12.21M | 2.54M | 1.82M | 1.75M | 1.65M | 1.36M | 1.02M | 910.72K | 605.31K |
| shares | — | 12.21M | 2.54M | 1.82M | 1.75M | 1.65M | 1.36M | 1.02M | 910.72K | 605.31K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2021: $18.05M in buybacks.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Single Reportable Segment | $642,000 | $2,266,000 | $1,380,000 |